[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639897":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":45,"responsibleParty":80,"collaborators":83,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":91,"sex":97,"minAge":98,"maxAge":26,"enrollmentInfo":99,"targetDuration":26,"studyType":102,"phases":103,"briefSummary":105,"conditions":106,"keywords":110,"overallStatus":60,"whyStopped":26,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},{"fullName":5,"class":6},"Bogomolets National Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"CGM group","EXPERIMENTAL","Participants with prediabetes will be provided with a Real-Time Continuous Glucose Monitoring (RT-CGM) device to monitor their blood glucose along with educational materials to better understand and manage their prediabetes and other supporting services. Pre and post intervention surveys and investigation will be implemented. Participants will be utilizing RT-CGM device for 28 days and then followed up for 3-month participation.",[13],"Device: CGM Sibionics",{"label":15,"type":16,"description":17,"interventionNames":18},"traditional fingerstick glucometer","ACTIVE_COMPARATOR","Participants with prediabetes will be provided with traditional fingerstick glucometer device to self-monitor their blood glucose along with educational materials to better understand and manage their prediabetes and other supporting services. Pre and post intervention surveys and investigation will be implemented. Participants will be utilizing glucometer with at least 2-3 measurements per week for 28 days and then followed up for 3-month participation.",[19],"Device: On-Call Extra Glucometer",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","CGM Sibionics","A registered medical device for real-time monitoring of glucose levels in interstitial fluid.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"On-Call Extra Glucometer","Capillary glucose monitoring using fingerstick glucometer as per standard care.",[15],[32],{"name":33,"affiliation":5,"role":34},"Nazarii Kobyliak","PRINCIPAL_INVESTIGATOR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Nazarii Kobyliak, Professor","CONTACT","+380442356005","nazariikobyliak@gmail.com",{"name":42,"role":38,"phone":43,"phoneExt":26,"email":44},"Ilona Rudneva, Dr","0442356005","ilonarudneva57@gmail.com",[46,59,69],{"facility":47,"status":48,"city":49,"state":26,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":26},"Bogomoletz Institute of Physiology","ENROLLING_BY_INVITATION","Kyiv","01024","Ukraine","UA",{"type":54,"coordinates":55},"Point",[56,57],30.5238,50.45466,{"lat":57,"lon":56},{"facility":5,"status":60,"city":49,"state":26,"zip":61,"country":51,"countryCode":52,"cosmosGeoPoint":62,"geoPoint":64,"contacts":65},"RECRUITING","01601",{"type":54,"coordinates":63},[56,57],{"lat":57,"lon":56},[66,67],{"name":37,"role":38,"phone":43,"phoneExt":26,"email":40},{"name":68,"role":38,"phone":26,"phoneExt":26,"email":44},"Victoriia Yerokhovych, PhD",{"facility":70,"status":60,"city":49,"state":26,"zip":61,"country":51,"countryCode":52,"cosmosGeoPoint":71,"geoPoint":73,"contacts":74},"University Hospital of Bogomolets National Medical University",{"type":54,"coordinates":72},[56,57],{"lat":57,"lon":56},[75,77],{"name":76,"role":38,"phone":43,"phoneExt":26,"email":44},"Ilona Rudneva, PhD student",{"name":78,"role":38,"phone":43,"phoneExt":26,"email":79},"Ieva Ilkiv, PhD Student","evailkiv333@gmail.com",{"type":81,"investigatorFullName":33,"investigatorTitle":82,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"SPONSOR_INVESTIGATOR","Vice Rector for Research and Innovation",[84,87],{"name":85,"class":86},"COR-Medical LLC","UNKNOWN",{"name":88,"class":86},"Iridium LLC","100639897","prediabetes-glycemic-impact-and-data-evaluation-100639897",false,"NCT07599072","PREdiabetes GLycemic Impact and Data Evaluation","Evaluation of the Impact of Continuous Glucose Monitoring (CGM) Systems on Glycemic Control in People With Prediabetes: Postmarketing Clinical Study","PRE-GLIDE","Inclusion Criteria:\n\n* Age of 18 years and older.\n* Presence of prediabetes diagnosed according to criteria of the American Diabetes Association\n* Persons who treated with diet and exercise alone or metformin on a stabilized dose for at least 3 months before the study;\n* Ability to comply with protocol requirements and maintain a patient diary.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Presence of type 1 or type 2 diabetes;\n* Decompensated liver or kidney diseases (GFR \\\u003C 45 ml\u002Fmin\u002F1. 73 m²);\n* Active cardiovascular diseases within 12 months of Visit 1, such as myocardial infarction, clinically significant arrhythmia, unstable angina, coronary artery bypass surgery, or angioplasty; or are expected to require coronary artery bypass surgery or angioplasty during the course of the study;\n* Endocrine disorders (e.g., Itsenko-Cushing syndrome, acromegaly) that affect glycemia;\n* Pregnancy or lactation;\n* Mental or cognitive impairments that would interfere with study participation;\n* Daily use of any form of steroid medication (oral, inhaled, injected) within the last 3 months;\n* Recent use of any CGM within the last 12 months;\n* Known allergy to sensor materials;\n* Has evidence of current abuse of drugs or alcohol or a history of abuse that, in the investigator's opinion, would cause the individual to be noncompliant;\n* Participation in another clinical study within the last 3 months.","ALL","18 Years",{"count":100,"type":101},80,"ESTIMATED","INTERVENTIONAL",[104],"NA","This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized tool that increases patient adherence to lifestyle changes compared to conventional SMBG methods.",[107,108,109],"Pre Diabetic","Obesity & Overweight","Insulin Resistance",[111,112,113,114,115],"prediabetes","obesity","continuous glucose monitoring","insulin resistance","traditional glycemia self-monitoring","2026-06-29",{"date":118,"type":119},"2026-06-30","ACTUAL",{"date":121,"type":101},"2026-07-01",{"date":123,"type":101},"2027-06-30",{"name":33,"class":6},3]